Bio-Path Holdings, Inc. (BPTH) vs Curis, Inc. (CRIS)

Bio-Path Holdings, Inc. and Curis, Inc. are both Biotechnology companies. Bio-Path Holdings, Inc. and Curis, Inc. are of similar size ($1.1M and $1.1M). Across the 9 metrics below, Curis, Inc. leads on 5 and Bio-Path Holdings, Inc. on 4.

Valuation

Metric BPTH CRIS Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.09 9.71
P/B n/m 0.19 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.00 0.41 0.64
EV/Sales n/m (0.37) 9.21
Earnings yield 0.00% (3,468.29%) (33.15%)
Free cash flow yield 0.00% (3,540.29%) (25.50%)

Profitability

Metric BPTH CRIS Biotechnology median
Gross margin 0.00% 99.52% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 157.01% 455.35% (56.36%)
Return on assets (605.50%) (87.76%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BPTH CRIS Biotechnology median
Revenue growth (TTM) — (13.43%) 6.02%
EPS growth (last fiscal year) 87.75% 91.57% 30.26%
Revenue growth, 5-year CAGR — (2.71%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BPTH CRIS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.07 0.49 4.72
Net debt to EBITDA 0.10 0.91 0.96

Dividend

Metric BPTH CRIS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BPTH CRIS Biotechnology median
Market cap 1.07m 1.06m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack